Fig. 2From: Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patientsAssociation of lymphocyte subset alterations with comorbidity in COVID-19 patients. The count (A) and proportion (B) of lymphocyte subset differences between COVID-19 patients with and without comorbidity. The count (C) and proportion (D) of lymphocyte subset differences between mild COVID-19 patients with and without comorbidity. The count (E) and proportion (F) of lymphocyte subset differences between severe COVID-19 patients with and without comorbidity. The differences were compared using the Mann-Whitney U test. NS, not significantBack to article page